top of page
Treating Cancer With Precision
News​
Categories
Sign up
Featured Posts
Archive
Follow Us
Oct 26, 2021
Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective
JERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
Oct 12, 2021
Meet Alpha Tau at ASTRO Chicago 2021
We are thrilled to announce that the Alpha Tau team will be attending (IN PERSON this year - Finally ! ) the ASTRO conference in Chicago....
Oct 12, 2021
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
JERUSALEM, Oct. 8, 2021 -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRTâ„¢, is pleased to...
bottom of page